Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model.
García-Castillo V, López-Urrutia E, Villanueva-Sánchez O, Ávila-Rodríguez MÁ, Zentella-Dehesa A, Cortés-González C, López-Camarillo C, Jacobo-Herrera NJ, Pérez-Plasencia C. García-Castillo V, et al. J Cancer. 2017 Jan 13;8(2):178-189. doi: 10.7150/jca.16387. eCollection 2017. J Cancer. 2017. PMID: 28243322 Free PMC article.
Selective Acetogenins and Their Potential as Anticancer Agents.
Jacobo-Herrera N, Pérez-Plasencia C, Castro-Torres VA, Martínez-Vázquez M, González-Esquinca AR, Zentella-Dehesa A. Jacobo-Herrera N, et al. Front Pharmacol. 2019 Jul 18;10:783. doi: 10.3389/fphar.2019.00783. eCollection 2019. Front Pharmacol. 2019. PMID: 31379567 Free PMC article. Review.
Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer.
Contreras-Romero C, Pérez-Yépez EA, Martinez-Gutierrez AD, Campos-Parra A, Zentella-Dehesa A, Jacobo-Herrera N, López-Camarillo C, Corredor-Alonso G, Martínez-Coronel J, Rodríguez-Dorantes M, de León DC, Pérez-Plasencia C. Contreras-Romero C, et al. Front Oncol. 2022 Mar 3;12:773438. doi: 10.3389/fonc.2022.773438. eCollection 2022. Front Oncol. 2022. PMID: 35359376 Free PMC article.
The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol.
López-Méndez JA, Ventura-Gallegos JL, Camacho-Arroyo I, Lizano M, Cabrera-Quintero AJ, Romero-Córdoba SL, Martínez-Vázquez M, Jacobo-Herrera NJ, León-Del-Río A, Paredes-Villa AA, Zentella-Dehesa A. López-Méndez JA, et al. Among authors: zentella dehesa a. Oncol Lett. 2023 Nov 15;27(1):19. doi: 10.3892/ol.2023.14152. eCollection 2024 Jan. Oncol Lett. 2023. PMID: 38034484 Free PMC article.
92 results